Product Information
TRESIBA FLEXTOUCH 100 UNIT/ML is a brand product labeled by Novo Nordisk, priced at $9.0425 per ML under NDC 00169266015. Its NADAC has been published 528 times since May 18, 2016.
Strength
100 U/mL
Manufacturer
Novo NordiskNDC
00169266015
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Last Updated
6/17/2026
Active Ingredients
INSULIN DEGLUDECApproval Type
Biologic (BLA)
FDA Application
BLA203314On Market Since
9/25/2015
Pharmacological Classes
Price Statistics
The NADAC for TRESIBA FLEXTOUCH 100 UNIT/ML has been published 528 times since May 18, 2016, and over the history we have for it it has declined 68.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.0425 per ML |
|---|---|
| All-time high | $32.6003 (Aug 12, 2020) |
| All-time low | $9.0299 (May 20, 2026) |
| 52-week high | $32.5361 |
| 52-week low | $9.0299 |
| Median price | $32.5258 |
| Average price | $30.6054 |
| Largest weekly change | -72.2% (Jan 14, 2026) |
| Weeks tracked | 528 |
| Tracking since | May 18, 2016 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TRESIBA FLEXTOUCH 100 UNIT/ML?
The current National Average Drug Acquisition Cost (NADAC) for TRESIBA FLEXTOUCH 100 UNIT/ML, manufactured by Novo Nordisk, is $9.0425 per ML (NDC 00169266015), effective Jun 24, 2026.
How has the price of TRESIBA FLEXTOUCH 100 UNIT/ML changed over time?
Over the history we have for it, the NADAC for TRESIBA FLEXTOUCH 100 UNIT/ML has declined 68.2%. It has been tracked across 528 weekly CMS publications since May 18, 2016.
What are the highest and lowest recorded NADAC prices for TRESIBA FLEXTOUCH 100 UNIT/ML?
Since May 18, 2016, the NADAC for TRESIBA FLEXTOUCH 100 UNIT/ML has ranged from a low of $9.0299 (May 20, 2026) to a high of $32.6003 (Aug 12, 2020), with a median of $32.5258 per ML.
Are there cheaper alternatives to TRESIBA FLEXTOUCH 100 UNIT/ML?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, TRESIBA 100 UNIT/ML VIAL, is $9.0243 per ML — about 0% below TRESIBA FLEXTOUCH 100 UNIT/ML.
Who manufactures TRESIBA FLEXTOUCH 100 UNIT/ML?
TRESIBA FLEXTOUCH 100 UNIT/ML (NDC 00169266015) is labeled by Novo Nordisk, and CMS classifies it as a brand product.
Related Drugs
Same classification